Befotertinib can simultaneously target classical EGFR-sensitive mutations and T790M resistance mutations, and exhibits excellent systemic and intracranial response efficacy.
Authentic
Guarantee
Fast Delivery
Privacy Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



